Researchers find adverse drug events are frequent and many are preventable in the outpatient setting

Credit: Pietro Jeng from Pexels Rachel L. Wasserman, PharmD, of the Department of General Internal Medicine at Brigham and Women’s Hospital, is the lead author and David W. Bates, MD, medical director of Clinical and Quality Analysis for Mass General Brigham and Co-Director of the Center for Artificial Intelligence and BioInformatics for Mass General Brigham, is the senior author of a new study published in BMJ Quality & Safety, “Frequency and preventability of adverse drug events in the outpatient setting.” Here, they answer questions about their research. How would you Read More

Related posts:

  1. New biomarker identified for predicting adverse events of tuberculosis therapy
  2. Semaglutide found to cut major adverse cardiovascular events in people with overweight, obesity
  3. Social media found to be associated with more frequent vaccination
  4. Researchers examine cancer drug guidelines and FDA approvals
  5. Researchers unveils a critical role of the lateral septum in drug addiction
  6. Researchers develop new compound designed to treat drug-resistant acute myeloid leukemia
  7. Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover
  8. Five-minute test leads to better care for people with dementia in the primary care setting

Leave a Reply

Your email address will not be published. Required fields are marked *